Anzeige
Mehr »
Login
Mittwoch, 14.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Metriken auf Strong Buy: Starker Ausbruch erwartet! Nach oben alles offen!?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AJKS ISIN: FR0013154002 Ticker-Symbol: 56S1 
Tradegate
14.04.21
16:13 Uhr
376,40 Euro
+2,60
+0,70 %
Branche
Biotechnologie
Aktienmarkt
CAC Next 20
1-Jahres-Chart
SARTORIUS STEDIM BIOTECH SA Chart 1 Jahr
5-Tage-Chart
SARTORIUS STEDIM BIOTECH SA 5-Tage-Chart
RealtimeGeldBriefZeit
375,40375,6016:33
375,30375,7016:33
Dow Jones News
1.811 Leser
Artikel bewerten:
(2)

Sartorius Stedim Biotech SA: Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them

DJ Sartorius Stedim Biotech SA: Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them

Sartorius Stedim Biotech SA 
Sartorius Stedim Biotech SA: Notification of transactions made by persons 
discharging managerial responsibilities and persons closely related to them 
 
02-Nov-2020 / 18:30 CET/CEST 
Dissemination of a French Regulatory News, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
 
    Notification of transactions made by persons discharging managerial 
            responsibilities and persons closely related to them 
 
                1. Contact information for the person discharging managerial 
                              responsibilities or the closely related person 
 
Company name: Sartorius AG 
 
Legal form: AG (Aktiengesellschaft) 
 
2. Reason for notification 
 
The declarant is a closely related person referred to in Article 3.26) of EU 
                      Regulation 596/2014 of April 16, 2014 on market abuse. 
 
Please specify the positions held within the issuer. 
 
     Positions: i. Joachim Kreuzburg is chairman and CEO of Sartorius Stedim 
            Biotech SA and chairman of the management board of Sartorius AG; 
 
  ii. Dr. René Fáber is a member of the board of Sartorius Stedim Biotech SA 
                       and a member of the management board of Sartorius AG; 
 
iii. Dr. Lothar Kappich is a member of the board of Sartorius Stedim Biotech 
                   SA and chairman of the supervisory board of Sartorius AG. 
 
This is an initial notification. 
 
3. Contact information of the issuer 
 
Company name: Sartorius Stedim Biotech S.A. 
 
LEI: 52990006IVXY7GCSSR39 
 
4. Information about the transaction 
 
Date of the transaction: 02/11/2020 
 
Place of the transaction: outside a trading venue 
 
Nature of the transaction: sale 
 
Description of the financial instrument: shares 
 
Identification code: FR0013154002 
 
Detailed information by transaction: 
 
                                                      Unit price: EUR 327.00 
 
                                                      Volume: 405,887 shares 
 
                                                     Aggregated information: 
 
                                          Weighted average price: EUR 327.00 
 
                                                      Volume: 405,887 shares 
 
 The transaction is NOT related to the exercise of a stock option program or 
                                      to a bonus or performance share grant. 
 
5. Comments 
 
? 
 
Regulatory filing PDF file 
 
File: Notification of transactions made by persons discharging managerial 
responsibilities and persons closely related to them [1] 
 
Language:        English 
Company:         Sartorius Stedim Biotech SA 
                 Avenue de Jouques 
                 13781 Aubagne 
                 France 
Phone:           +33 44 284 5600 
E-mail:          info@sartorius-stedim.com 
Internet:        www.sartorius-stedim.com 
ISIN:            FR0013154002 
Euronext Ticker: DIM 
AMF Category:    Inside information / Other releases 
EQS News ID:     1144863 
 
End of Announcement EQS News Service 
 
1144863 02-Nov-2020 CET/CEST 
 
 
1: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=1a4a1a3aa3b50764b160a61df68f2b7c&application_id=1144863&site_id=vwd&application_name=news 
 

(END) Dow Jones Newswires

November 02, 2020 12:30 ET (17:30 GMT)

SARTORIUS STEDIM BIOTECH-Aktie komplett kostenlos handeln - auf Smartbroker.de
© 2020 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.